Cardiome Pharma Corp (NASDAQ:CRME)

9.22
Delayed Data
As of May 26
 -0.11 / -1.18%
Today’s Change
5.84
Today|||52-Week Range
11.31
-0.32%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues1.5M789.0K4.5M30.0M
 
 
 
 
 
Cost of Goods Sold15.2M--936.0K10.0M
 
 
 
 
Depreciation And Amortization1.1M1.2M649.0K2.2M
 
 
 
 
 
 
Operating ExpensesGross Income-14.8M--2.9M17.9M
 
 
 
 
General Expenses11.5M15.6M16.9M34.5M
 
 
 
 
 
Research And Development--6.0M476.0K637.0K
 
 
 
 
Total Operating Expenses27.9M16.9M18.5M46.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-26.4M-16.1M-14.0M-16.6M
 
 
 
 
 
Extraordinary Credit0.0011.2M20.8M0.00
 
 
 
Extraordinary Charge-95.0K-10.0M-2.7M0.00
 
 
 
 
Interest Expense On Debt2.2M4.3M87.0K1.5M
 
 
 
 
 
Other Expenses756.0K843.0K825.0K-110.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-27.9M-18.3M4.9M-18.2M
 
 
 
 
 
Income Taxes0.000.00-102.0K-49.0K
 
 
 
Net Income-27.9M-18.3M4.8M-18.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS12.2M12.3M12.8M16.2M
 
 
 
 
 
Shares To Calculate EPS Diluted12.2M12.3M12.9M16.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.30-$1.50$0.37-$1.12
 
 
 
 
 
EPS Diluted-$2.30-$1.50$0.37-$1.12
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account